On February 7, 2022 Evogene Ltd. (NASDAQ-GM: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across several market segments reported that it will present a company overview at the Aegis Capital Corp. Virtual Conference to be held on February 25th at 9:00 Eastern (Press release, Evogene, FEB 7, 2022, View Source [SID1234607808]). The conference will span three days, starting on February 23rd until February 25th from 8:30AM until 5PM EST.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Evogene’s presentation will be available by request to Aegis from February 23 to 25, 2022. The slide deck will also be made available on Evogene’s website at View Source
To access the event, please download and import the following iCalendar (.ics) files to your calendar system: Aegis Virtual Conference Calendar